http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2007008631-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7f82940e47ba7a1188f8e2ffca55e0f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-885
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-77
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-88
filingDate 2006-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_163e5881cf7d68a85d3de2f9d3028421
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35f633104351296e22db3a6ab938a1cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be4a92bab913e8b38fa87509d9e333d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c4e870f8d0aa1f05a645740ad5fe797
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92d52f3ed351280e9b97c292bcbfa32a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9546295154c23ad61b805065615dc57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_771844c419b851f9c021eeb7b5ba40bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6d1047965645fcbe90313841d590e32
publicationDate 2007-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2007008631-A
titleOfInvention SYNTHESIS OF ANALOGS OF HIMBACINA.
abstract The present invention relates to an improved method for preparing analogs of himbacin; the compounds are useful as thrombin receptor antagonists; the improved process may allow at least one purification by crystallization, scalability or improved process performance of the simplest desired enantiomer; An example of a stage in the synthesis of this type of himbacin analog is the following: Formula (I).
priorityDate 2005-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419499944
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6436265

Total number of triples: 29.